Hepatitis B in Immigrant Populations: Breaking Barriers and Improving Outcomes
Including proceedings of a national series of lunch and learn meetings
Activity Date: December 2009  — Activity Info: Volume 9, (3)
 

Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.


Policy on Faculty and Provider Disclosure

It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the educational activity. The Course Directors and Participating Faculty reported the following:


Jane C. Shivnan, MScN, RN, AOCN

Executive Director

The Institute for Johns Hopkins Nursing

Baltimore, Maryland

Ms Shivnan reports having no significant financial or advisory relationships with corporate organizations related to this activity.


COURSE DIRECTORS

Ahmet Gurakar, MD
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Medical Director, Liver Transplantation
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Gurakar reports serving on the speakers’ bureau for Schering-Plough Corporation.

Susan L. Humphreys, RN, MS
Nurse Manager
The Johns Hopkins Hospital Kidney
Transplant Program
Comprehensive Transplant Center
Baltimore, Maryland
Ms Humphreys reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Tarek Hassanein, MD
Professor of Clinical Medicine and Surgery
Division of Gastroenterology and Hepatology
Medical Director of Liver Transplantation
Director of Liver Clinical Trials Center
University of California
San Diego, California
Dr Hassanein reports serving as the principal investigator on grants from Bayer, Gilead Pharmaceuticals, GlaxoSmithKline, Nexavar, Roche Pharmaceuticals, and Vertex Pharmaceuticals; and serving on the speakers’ bureau for Gilead Pharmaceuticals, Nexavar, Roche Pharmaceuticals, and Schering-Plough/Merck.

Norman L. Sussman, MD
Professor of Medicine
Director of Hepatology
University of Utah
Salt Lake City, Utah
Dr Sussman reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

NURSE PLANNER

Jane C. Shivnan, MScN, RN, AOCN
Executive Director, Institute for Johns Hopkins Nursing
Baltimore, Maryland
Ms Shivnan reports having no relationships with commercial interests related to this activity.

Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).


Notice: The audience is advised that no faculty member in this CME/CNE activity references unlabeled or unapproved uses of drugs or devices.


Non-Endorsement of Products

The Institute for Johns Hopkins Nursing does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.


     
Home | Contact Us | View Account | Need Help? | Subscription